Imprimis Pharmaceuticals, Inc.

Quick facts

Phase 3 pipeline

• Topical Ketoprofen 10% Cream · Pain Management / Rheumatology
  Ketoprofen is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis, thereby decreasing inflammation and pain at the site of topical application.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Imprimis Pharmaceuticals, Inc. portfolio CI brief
• Imprimis Pharmaceuticals, Inc. pipeline updates RSS